Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Garo H Armen PhDChairman & CEO1,548,8831.78%2016-06-29
Chadarevian Gamil DeN/A88,6100.1%2006-02-28
Shalini SharpN/A81,311less than 0.1%2013-01-30
Karen ValentineN/A68,288less than 0.1%2016-04-26
Mr. John N. HatsopoulosN/A65,000less than 0.1%2009-02-25
Kerry WentworthN/A57,410less than 0.1%2014-02-26
Christine KlaskinN/A52,816less than 0.1%2016-04-26
Ozer BaysalChief Business Officer33,633less than 0.1%2016-04-26
Mr. Ulf WiinbergDirector30,000less than 0.1%2016-09-06
C. Evan BallantyneN/A24,795less than 0.1%2016-04-26

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
WIINBERG ULFDirector2016-09-06Buy30,00030,000$6.29188.7-34.8230,000 (Direct)
ARMEN GARO HChairman & CEO
(Click for the stocks that their CEOs have bought)
2016-05-09Buy100,0001,396,026$3.1831828.931,396,026 (Direct)
ARMEN GARO HChairman & CEO2016-05-09Buy100,0001,396,026$3.1831828.931,396,026 (Direct)
Baysal OzerChief Business Officer2016-05-05Buy2,25033,538$3.16.9832.2633,538 (Direct)
ARMEN GARO HChairman & CEO2016-03-07Buy200,0001,251,228$4.038061.741,251,228 (Direct)
ARMEN GARO HChairman & CEO2015-12-29Sell219,5761,271,577$4.591007.85-10.681,051,228 (Direct)
220,349 (by Trust and Antigenics Holdings)
ARMEN GARO HChairman & CEO2015-09-25Buy100,0001,713,653$5.03503-18.491,409,607 (Direct)
304,046 (by Trust and Antigenics Holdings)
Ballantyne Charles EvanCFO2015-09-25Buy10,00010,000$5.0550.5-18.8110,000 (Direct)
Malik ShahzadDirector2015-04-29Sell1,107,3770$7.117873.45-42.33
0 (see footnote)
QVT Associates GP LLC10% Owner2015-01-09Sell2,343,6306,915,630$5.3112444.68-22.79
6,915,630 (Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.)
Wentworth KerryVP, Clinical, Reg & Qual2014-02-26Sell5,00057,410$525-1857,410 (Direct)
Valentine KarenVP General Counsel2014-01-23Sell2,85051,534$3.59.9817.1451,534 (Direct)
Sharp ShaliniDirector2013-01-30Sell28881,311$4.361.26-5.9681,311 (Direct)
Sharp ShaliniDirector2012-10-31Sell28880,974$4.41.27-6.8280,974 (Direct)
Sharp ShaliniDirector2012-08-29Sell28876,602$4.641.34-11.6476,602 (Direct)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK